scholarly journals Screening for abnormal glycosylation in a cohort of adult liver disease patients

2020 ◽  
Vol 43 (6) ◽  
pp. 1310-1320
Author(s):  
Jos C. Jansen ◽  
Bart Hoek ◽  
Herold J. Metselaar ◽  
Aad P. Berg ◽  
Fokje Zijlstra ◽  
...  
2021 ◽  
Vol 8 ◽  
Author(s):  
Anna Bogdańska ◽  
Patryk Lipiński ◽  
Paulina Szymańska-Rożek ◽  
Irena Jankowska ◽  
Piotr Socha ◽  
...  

Background: Isoelectric focusing (IEF) of serum transferrin (Tf) is still the method of choice for diagnosis of congenital disorders of glycosylation (CDG). An abnormal glycosylation is also a known phenomenon in adult liver disease patients. The aim of this study was to characterize glycosylation disturbances in pediatric patients with primary liver disease. However, there are no reports of this phenomenon in children.Materials and Methods: Between 1995 and 2019, circa 2,000 serum Tf isoform analyses have been performed in children with primary liver diseases; some of them underwent subsequent analyses. We enrolled in this study 19 patients who developed an acute liver injury (ALI)/failure (ALF) or exhibited a chronic liver disease (CLD) and were evaluated and listed for liver transplantation (LTx) or had just undergone this procedure, and secondary abnormal serum Tf isoform profile.Results: Among 12 patients with ALI/ALF, 10 had an increased percentage of asialo-, monosialo-, and disialo-Tf isoforms. All patients with CLD had an increased percentage of asialo- and monosialo-Tf isoform. Two patients diagnosed with recurrent ALF had very specific serum Tf profile with a huge increase in the asialo- and monosialo-Tf isoform. On follow-up analyses (available in some patients), serum Tf IEF profile normalized in parallel to normalization of liver function tests, spontaneously or during treatment, including glucocorticosteroids in AIH, LTx in CLD.Conclusions: All pediatric patients with primary liver disease had increased asialo-Tf as well as monosialo-Tf isoforms. None of them had elevated percentage of trisialo-Tf isoform.


2009 ◽  
Vol 114 (4) ◽  
pp. 228-234 ◽  
Author(s):  
Aleksandra Topic ◽  
Tamara Alempijevic ◽  
Aleksandra Sokic Milutinovic ◽  
Nada Kovacevic

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Vandana Jain ◽  
Charlotte Burford ◽  
Emma C. Alexander ◽  
Anil Dhawan ◽  
Deepak Joshi ◽  
...  

Author(s):  
Luigi Aloia

The adult liver has excellent regenerative potential following injury. In contrast to other organs of the body that have high cellular turnover during homeostasis (e.g., intestine, stomach, and skin), the adult liver is a slowly self-renewing organ and does not contain a defined stem-cell compartment that maintains homeostasis. However, tissue damage induces significant proliferation across the liver and can trigger cell-fate changes, such as trans-differentiation and de-differentiation into liver progenitors, which contribute to efficient tissue regeneration and restoration of liver functions. Epigenetic mechanisms have been shown to regulate cell-fate decisions in both embryonic and adult tissues in response to environmental cues. Underlying their relevance in liver biology, expression levels and epigenetic activity of chromatin modifiers are often altered in chronic liver disease and liver cancer. In this review, I examine the role of several chromatin modifiers in the regulation of cell-fate changes that determine efficient adult liver epithelial regeneration in response to tissue injury in mouse models. Specifically, I focus on epigenetic mechanisms such as chromatin remodelling, DNA methylation and hydroxymethylation, and histone methylation and deacetylation. Finally, I address how altered epigenetic mechanisms and the interplay between epigenetics and metabolism may contribute to the initiation and progression of liver disease and cancer.


2010 ◽  
Vol 23 (4) ◽  
pp. 350-357 ◽  
Author(s):  
Kensaku Sanefuji ◽  
Tomohiro Iguchi ◽  
Shigeru Ueda ◽  
Shigeyuki Nagata ◽  
Keishi Sugimachi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document